Search Results
Mar 31, 2026, 05:00 ET Resilience Care Expands to U.S. Market, Adds Veteran Digital Health Leaders to Support Growth with Oncology Providers
entry and growth is a powerhouse US advisory board of digital health and oncology industry veterans, including:Eddie Martucci, PhD (President, U.S.): Biotech entrepreneur and co-founder of Akili Interactive, known for securing the first FDA authorization for a prescription digital
More news about: Resilience Care
Mar 30, 2026, 17:40 ET BTQ Technologies Provides Full-Year 2025 Corporate Update Highlighting Commercial Progress Across QCIM, QPerfect, QSSN and Bitcoin Quantum
securing its call option as part of the pathway toward full integration. During the quarter, QPerfect brought its team to full strength with eight new PhD-level hires across research, development, hardware, DevOps, and applications, while also publishing three research papers focused on benchmarking quantum
More news about: BTQ Technologies Corp.
Mar 30, 2026, 16:00 ET Devonian Reports Results of its Annual General and Special Meeting of Shareholders
Wainwright and co-founder of DiamiR Biosciences. She brings deep expertise in healthcare fundraising, strategic advisory, and operations. She holds a PhD in Biomedical Sciences from Mount Sinai School of Medicine and an Honors MBA from Baruch College.Luc Buisson is a Senior Strategic and
More news about: Devonian Health Group Inc.
Mar 30, 2026, 12:34 ET Skyhawk Therapeutics Announces its Founding Scientific Advisory Board Chairman Receives the American Cancer Society's 2026 Medal of Honor
extraordinary scientist and leader across many fields and organizations. His recognition from ACS is richly deserved," said Dr. Benjamin L. Ebert, MD, PhD, co-founding member of Skyhawk's SAB and President and CEO of Dana-Farber Cancer Institute. "As founding Chairman of Skyhawk's SAB, Tyler has been a
More news about: Skyhawk Therapeutics
Mar 30, 2026, 10:14 ET CurePSP Convenes Bipartisan Congressional Briefing to Advance PSP, CBD and MSA Research
all its services. CurePSP is a registered 501(c)(3) charity within the United States (EIN: 52-1704978).Contact:Kristophe Diaz, PhDChief Executive [email protected]
More news about: CurePSP, Inc.
Mar 30, 2026, 09:25 ET FDA Approves High Dose Regimen of SPINRAZA for People Living with SMA
ensuring individuals and families living with SMA understand what this means and making sure they have a clear path to access," said Jackie Glascock, PhD, Chief Scientific Officer at Cure SMA. "We are committed to partnering with Biogen and healthcare providers to support education, access, and implementation
More news about: Cure SMA
Mar 30, 2026, 09:00 ET Jefferson is First Organization to Earn URAC's Community Health Worker Program Accreditation
"At Jefferson, we believe community health workers are essential to advancing equitable care," said Christine James, PhD, LSW, Director of the Community Health Worker Academy. "Becoming the first organization in the country to earn URAC's accreditation validates the strength
More news about: URAC
Mar 30, 2026, 08:30 ET Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31
biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced Helen Sabzevari, PhD, President and CEO, and Phil Tennant, Chief Commercial Officer, of Precigen, will participate in a virtual fireside chat with H.C. Wainwright on March
More news about: Precigen, Inc.
Mar 29, 2026, 20:30 ET Insilico Medicine Announces Global R&D Collaboration with Lilly
world models of human and animal life, we can identify multi-purpose targets driving multiple diseases at the same time," said Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine. "Working with Lilly, we aim to deliver transformative therapies that treat diseases with high unmet need.
More news about: Insilico Medicine
Mar 29, 2026, 18:09 ET Better by MTA amplía su red mundial de élite con nuevos miembros Platinum distinguidos
anillos intracorneales y procedimientos refractivos. Los servicios están disponibles en inglés, español y hebreo.Dr. Patrick Tonnard, MD, PhDDirector ejecutivo y fundador, Centro de Cirugía Plástica y Medicina Estética Coupure 2 (EMC²) – Gante, BélgicaEl Dr. Patrick Tonnard
More news about: Medical Tourism Association
Mar 29, 2026, 18:06 ET Better by MTA amplia sua rede global de elite com novos e renomados membros Platinum
de anel intracorneano e procedimentos refrativos. Os serviços estão disponíveis em inglês, espanhol e hebraico.Dr. Patrick Tonnard, MD, PhDCEO e fundador do Coupure Center for Plastic Surgery & Aesthetic Medical Center 2 (EMC²) – Ghent, BélgicaDr. Patrick Tonnard
More news about: Medical Tourism Association
Mar 29, 2026, 08:57 ET n6 Launches icon16™, Expanding AutoNorm™ Adaptive Amplification to Lower-Throughput NGS Workflows
"Sequencing technology has advanced rapidly, but the thermocycler at the center of library preparation has barely changed in decades," said Pranav Patel, PhD, MBA, co-founder and CEO of n6. "With icon96 we introduced AutoNorm to replace the one-size-fits-all approach to amplification. icon16
More news about: n6
Mar 28, 2026, 14:00 ET Dual Imaging Identifies Cause of Heart Attack in Patients Without Blocked Arteries
Chang Yu, PhD; and
More news about: NYU Langone Health
Mar 28, 2026, 12:36 ET Data from Phase 2b REZOLVE-AD and REZOLVE-AA Studies of Rezpegaldesleukin Presented at 2026 American Academy of Dermatology Annual Meeting
standard of care biologic treatment, which can have lower response rates in more severe patients as compared to moderate patients," said Raj Chovatiya, MD, PhD, MSCI, FAAD. "We believe its novel agonist mechanism to expand regulatory T cells, which act as master regulators upstream of the cytokine-specific blockade
More news about: Nektar Therapeutics
Mar 28, 2026, 10:38 ET HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism
of the impact of intervention via ultrasound-facilitated catheter-directed thrombolysis with the EKOS system," said Dr. Stavros Konstantinides, MD, PhD, FESC, principal investigator of the HI-PEITHO trial and medical director, Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany.*
More news about: Boston Scientific Corporation
Mar 27, 2026, 17:31 ET Shrub Oak International School Announces Janine D'Anna, M.S. Ed., as Assistant Director of Education
forward to building on the incredible work already taking place across our programs."As a lifelong learner, she is also currently pursuing her PhD at Thomas Jefferson University.About Shrub Oak International School and The Pines at Shrub OakThe mission of Shrub Oak International
More news about: Shrub Oak International School
Mar 27, 2026, 16:45 ET Allergy & Asthma Network and Blue Marble Health Advance Digital Health Innovation with Evidence-Based Platform for Asthma Self-Management
Health's approach: technology built with patients and clinicians, not just for them, produces platforms people actually want to use," Sheryl Flynn, PT, PhD, CEO of Blue Marble Health. "The strong usability and feasibility outcomes we achieved with our Health in Motion – BREATHE Platform give us tremendous
More news about: Allergy & Asthma Network
Mar 27, 2026, 10:34 ET Better by MTA Expands Its Global Elite Network with Distinguished New Platinum Members
intracorneal ring implantation, and refractive procedures. Services are available in English, Spanish, and Hebrew.Dr. Patrick Tonnard, MD, PhDCEO & Founder, Coupure Center for Plastic Surgery & Aesthetic Medical Center 2 (EMC²) – Ghent, BelgiumDr. Patrick Tonnard
More news about: Medical Tourism Association
Mar 27, 2026, 10:06 ET Better by MTA Expands Its Global Elite Network with Distinguished New Platinum Members
intracorneal ring implantation, and refractive procedures. Services are available in English, Spanish, and Hebrew.Dr. Patrick Tonnard, MD, PhDCEO & Founder, Coupure Center for Plastic Surgery & Aesthetic Medical Center 2 (EMC²) – Ghent, BelgiumDr. Patrick Tonnard
More news about: Medical Tourism Association
Mar 27, 2026, 09:57 ET /C O R R E C T I O N -- Spinogenix/
(p=0.042)."These results showcase the possibility for synaptic regeneration to shift our treatment approach in schizophrenia," said Dr. David Walling, PhD, Chief Clinical Officer at CenExel and Principal Investigator of the trial, who has been involved in schizophrenia drug development for over 30 years.
More news about: Spinogenix
Mar 27, 2026, 09:00 ET The future of skin aging may be found in the kitchen: 2026 American Academy of Dermatology Annual Meeting to highlight latest advancements in skin, hair, and nails
significantly affect self-esteem, social confidence, and overall mental well-being.Dawn Eichenfield, MD, FAAD, PhD, a board-certified dermatologist at Rady Children's Hospital-San Diego and an assistant clinical professor of dermatology at University of California,
More news about: American Academy of Dermatology
Mar 27, 2026, 08:38 ET BionicM and Brooks Rehabilitation Launch Clinical Study Comparing Powered Bio Leg to Microprocessor Knees
with transfemoral amputation who utilize prosthetic knee technology in daily life.The research is led by Principal Investigator Emily J. Fox, PhD, DPT, MHS, director of neuromuscular research at Brooks Rehabilitation and the Brooks Motion Analysis Center, with clinical leadership and collaboration
More news about: BionicM LLC USA
Mar 27, 2026, 08:38 ET UMD Smith's Center for AI in Business Awarded $1M+ Federal Grant to Help Small Businesses Adopt AI
the University of Maryland, College Park, the Smith School offers undergraduate, full-time and flex MBA, executive MBA, online MBA, business master's, PhD and executive education programs, as well as outreach services to the corporate community. The school offers its degree, custom and certification programs
More news about: University of Maryland's Robert H. Smith School of Business
Mar 27, 2026, 07:30 ET Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at the SHM Converge
Authors: A. Sidney Barritt IV, MD; Kavish R. Patidar, DO; Robert J. Wong, MD, MS; Xingyue Huang, PhD; Rachel Black, PharmD; Mary Panaccio, PhD; Jonathan Lilley, BA; Nisha Wadhwani, PhD; Rahul Rajkumar, MD, MPH; Christopher White, MD, MSPHAbout Hepatorenal Syndrome-Acute Kidney
More news about: Keenova Therapeutics
Mar 27, 2026, 05:20 ET The Nomination Committee's proposal for the election of Board members and Chairperson of the Board in BioArctic AB
diagnosis and treatment of Alzheimer's disease. Prof. dr. Philip Scheltens studied at the VU University Amsterdam, Netherlands, gaining his MD in 1984, and PhD in 1993. He was appointed as Professor of Cognitive Neurology in 2000 and founded the Alzheimer Center at Amsterdam University Medical Centers in that
More news about: BioArctic